Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 25451868)

Published in Clin Chem on December 01, 2014

Authors

Ziad Hijazi1, Agneta Siegbahn2, Ulrika Andersson3, Bertil Lindahl4, Christopher B Granger5, John H Alexander5, Dan Atar6, Bernard J Gersh7, Michael Hanna8, Veli-Pekka Harjola9, John Horowitz10, Steen Husted11, Elaine M Hylek12, Renato D Lopes5, John J V McMurray13, Lars Wallentin4

Author Affiliations

1: Uppsala Clinical Research Center, Department of Medical Sciences, Cardiology, and ziad.hijazi@ucr.uu.se.
2: Uppsala Clinical Research Center, Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden;
3: Uppsala Clinical Research Center.
4: Uppsala Clinical Research Center, Department of Medical Sciences, Cardiology, and.
5: Duke University, Medical Center, Durham, NC;
6: Department of Cardiology, Oslo University Hospital and Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway;
7: Mayo Clinic College of Medicine, Rochester, MN;
8: Bristol-Myers Squibb, Princeton, NJ;
9: Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland;
10: University of Adelaide, Adelaide, Australia;
11: Medical Department, Hospital Unit West, Herning/Holstbro, Denmark;
12: Boston University Medical Center, Boston, MA;
13: BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, U.K.

Associated clinical trials:

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE) | NCT00412984